Health ❯Healthcare ❯Pharmaceuticals ❯Obesity Treatment

GLP-1 Medications

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

The small‑molecule, no‑restriction GLP‑1 pill presents a scalable alternative to injectables as regulators weigh its efficacy versus rivals.

Lilly’s Oral GLP-1 Pill Underperforms Wegovy in Late-Stage Trial

France to Let All Doctors Prescribe Wegovy and Mounjaro Starting June 23

Study Identifies Key Factors Influencing Weight Loss on GLP-1 RA Medications